The FDA has approved an injectable hyaluronic acid dermal filler for improvement of infraorbital hollowing.
The US Food and Drug Administration has approved an injectable hyaluronic acid dermal filler for improvement of infraorbital hollowing, the manufacturerThe product, which will be marketed by Galderma as Restylane Eyelight, is indicated for volume loss under the eyes in patients older than 21 years. The hyaluronic acid filler contains lidocaine for patient comfort.
Approval is based on a phase 3 trial that found that 87% of those treated showed improvement in under-eye hollows at 3 months. Improvement was defined as at least a 1-point improvement on a 4-point scale measuring the severity of the infraorbital hollows. In addition, 92% of participants were pleased with the results at 3 months, and 84% were pleased at 12 months, according to the press release. As for safety, 87% of patients had no side effects; most adverse effects were mild, and there were no severe side effects, according to the release. The most common adverse effects were swelling, redness, tenderness, pain, bruising, itching, and lumps or bumps at the injection site.
Restylane Eyelight should not be used by people with severe allergies, those with a history of anaphylaxis, or those who are allergic to lidocaine or to gram-positive bacterial proteins used to make hyaluronic acid. It also should not be used by people prone to bleeding or those with a bleeding disorder. Safety for patients who are pregnant or breastfeeding has not been studied, according to Galderma.
The treatment will be available across the United States over coming months, the company said. The first Restylane
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Acid partisanship drives fear America is being destroyedPolitical partisanship, once primarily the driver in voter attitudes about presidents, is now ripping the country apart, with each side believing that if the other side wins, America will be destroyed.
Weiterlesen »
Amino acid in energy drinks makes mice live longer and healthierA new study suggests boosting taurine levels increases life span in mice and improves the physical condition of middle-aged monkeys, hinting it could do the same for people.
Weiterlesen »
FDA OKs Letermovir to Prevent CMV in Kidney TransplantsLetermovir was shown to be just as effective as valganciclovir in preventing CMV in kidney transplant recipients in new study published in JAMA; results prompt additional FDA approval for this indication.
Weiterlesen »
FDA Finalizes Limit on How Much Arsenic Can Be in Apple JuiceFederal regulators have finalized new guidance on how much inorganic arsenic can be present in apple juice, in an effort to limit the exposure of infants and young children to this environmental contaminant.
Weiterlesen »
FDA clears Lynparza for prostate cancer treatmentThe Food and Drug Administration cleared a new cancer-fighting drug called Lynparza for prostate cancer treatment.
Weiterlesen »
FDA warns against self-diagnosis, bogus treatments for this common skin conditionThe Food and Drug Administration is warning against self-diagnosis and self-treatment for a common skin condition - a viral infection often called 'water warts.'
Weiterlesen »